Farah Zarka

Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies

M. Hudson, M. Fritzler, I. Targoff, 2020, RMD Open.

A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus Classification

Farah Zarka, Jean-Paul Makhzoum, C. Veillette, 2020, International journal of rheumatology.

Case of Severe Seronegative Autoimmune Rhombencephalitis Successfully Treated with Rituximab

T. Slaoui, Farah Zarka, Jean-Paul Makhzoum, 2021 .

Myositis with prominent B cell aggregates may meet classification criteria for sporadic inclusion body myositis

M. Hudson, F. Grand'Maison, M. Fritzler, 2022, Neuromuscular Disorders.

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

M. Hudson, S. Hussein, J. Raynauld, 2020, Arthritis Research & Therapy.

Risk of incident bleeding after acute kidney injury: A retrospective cohort study.

J. Bouchard, T. Ducruet, Farah Zarka, 2020, Journal of critical care.

Colour Doppler ultrasound and the giant cell arteritis probability score for the diagnosis of giant cell arteritis: a Canadian single-centre experience

M. Rhéaume, A. Mansour, Farah Zarka, 2021, Rheumatology advances in practice.